Xeris Biopharma Holdings, Inc. (XERS)
7.01
+0.02
(+0.29%)
USD |
NASDAQ |
Dec 09, 16:00
7.05
+0.04
(+0.57%)
After-Hours: 20:00
Xeris Biopharma Holdings Total Assets (Quarterly): 370.19M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Plus Therapeutics, Inc. | 18.67M |
| Assertio Holdings, Inc. | 319.78M |
| Amneal Pharmaceuticals, Inc. | 3.600B |
| NovaBay Pharmaceuticals, Inc. | 3.487M |
| Palatin Technologies, Inc. | 8.615M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 371.05M |
| Shareholders Equity (Quarterly) | -0.861M |
| Debt to Equity Ratio | -299.25 |
| Current Ratio | 1.928 |
| Net Debt Paydown Yield | 0.18% |